Green tea and EGCG extracts
Drinking green tea is safe and pleasant, but a Cochrane review found no consistent evidence that it prevents cancer, and concentrated green tea extract capsules have caused liver injury and can interfere with some drugs.
Overview
Epigallocatechin gallate (EGCG) and other catechins have antioxidant and signalling effects in cells. A 2020 Cochrane review of 142 studies, mostly observational plus a few randomised trials, found inconsistent and inconclusive evidence for cancer prevention by green tea, with low- to very-low-certainty results in both directions by cancer site. Randomised trials of EGCG extracts in prostate cancer precursors and chronic lymphocytic leukaemia showed biological activity without proven clinical benefit. Concentrated extracts (typically above 800 mg EGCG per day) are associated with hepatotoxicity, and EGCG can reduce the absorption or activity of bortezomib, some statins and beta-blockers. Tea as a beverage carries none of these concerns.
How it works
Catechins scavenge reactive oxygen species and modulate kinases and proteasome activity in vitro; effective concentrations are not reached by drinking tea.
- Safe as a beverage
- Extensive biological literature
- No consistent prevention effect in Cochrane review
- Extract hepatotoxicity
- Bortezomib interaction
Latest papers
topQuery for this technology: (TITLE:"Green tea and EGCG extracts" OR ABSTRACT:"Green tea and EGCG extracts") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Green tea and EGCG extracts, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyCurcumin and turmeric
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyAyurvedic medicine and cancer
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyMedicinal mushrooms: reishi, turkey tail, shiitake and others
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyMelatonin as a cancer adjunct
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyTraditional Chinese herbal medicine alongside treatment
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyReiki, healing touch and other energy therapies
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyCannabis and cannabinoids for pain, appetite and cancer control
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.
- TechnologyEssiac, Hoxsey and other 'herbal cancer cures'
Shares Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care, evidence:insufficient.